Skip to main content
. 2024 Aug 30;75:102782. doi: 10.1016/j.eclinm.2024.102782

Fig. 3.

Fig. 3

A: Cost savings with use of endoscopic sleeve gastroplasty vs. semaglutide over 5 years. B: Quality adjusted life years according to use of endoscopic sleeve gastroplasty vs. subcutaneous semaglutide 2.4 mg for weight loss at different time points.